To characterize the effects of CXCR4 blockade by LY2510294 with FLT3 inhibitors, we used FLT3-ITD-AML cell lines MV4–11 and MOLM-14, which express high levels of CXCR4 on their cell surface. This evidence concerns the gene FLT3 and acute myeloid leukemia.